Hydrochlorothiazide blocks the electroneutral Na+/Cl- co-transporter in the distal convoluted tubule, reducing sodium and chloride reabsorption. Increased delivery of sodium to the collecting duct promotes potassium and hydrogen loss, producing mild diuresis, decreased plasma volume, and long-term reductions in peripheral vascular resistance that lower blood pressure.